| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |



From the Second Department of Pathology,*
Kanazawa
University School of Medicine, Kanazawa; the Drug Safety Research
Laboratory,
Toyama Chemical Company Limited,
Toyama; and the College of Environmental
Health,
Azabu University, Sagamihara, Japan
Carolis disease (congenital intrahepatic biliary dilatation) associated with congenital hepatic fibrosis is an autosomal recessive polycystic kidney disease. Recently, the polycystic kidney (PCK) rat, a spontaneous mutant derived from a colony of Crj:CD rats with polycystic lesions in the liver and an autosomal recessive mode of inheritance, was reported. In the present study, the pathology of the hepatobiliary system and the biliary cell-kinetics were evaluated in fetuses (day 18 to 21 of gestation) and neonates and adults (1 day to 4 months after delivery) of PCK rats. Crj:CD rats were used as a control. Multiple segmental and saccular dilatations of intrahepatic bile ducts were first observed in fetuses at 19 days of gestation. The dilatation spread throughout the liver and the degree of dilatation increased with aging. Gross and histological features characterizing ductal plate malformation were common in the intrahepatic bile ducts. Overgrowth of portal connective tissue was evident and progressive after delivery. These features were very similar to those of Carolis disease with congenital hepatic fibrosis. Proliferative activity in the biliary epithelial cells was greater in PCK rats than controls during the development. In contrast, the biliary epithelial apoptosis was less extensive in PCK rats than the controls until 1 week after delivery, but greater after 3 weeks, suggesting that the remodeling defect in immature bile ducts associated with the imbalance of cell kinetics plays a role in the occurrence of intrahepatic biliary anomalies in PCK rats. The PCK rat could be a useful and promising animal model of Carolis disease with congenital hepatic fibrosis.
This article has been cited by other articles:
![]() |
W. E. Sweeney Jr, R. O. von Vigier, P. Frost, and E. D. Avner Src Inhibition Ameliorates Polycystic Kidney Disease J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1331 - 1341. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, K. Harada, S. Ozaki, S. Furubo, K. Kizawa, T. Sanzen, M. Yasoshima, H. Ikeda, M. Sasaki, and Y. Nakanuma Cholangiocytes with Mesenchymal Features Contribute to Progressive Hepatic Fibrosis of the Polycystic Kidney Rat Am. J. Pathol., December 1, 2007; 171(6): 1859 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, K. Harada, S. Furubo, K. Kizawa, T. Sanzen, M. Yasoshima, S. Ozaki, K. Isse, M. Sasaki, and Y. Nakanuma Inhibition of Intrahepatic Bile Duct Dilation of the Polycystic Kidney Rat with a Novel Tyrosine Kinase Inhibitor Gefitinib Am. J. Pathol., October 1, 2006; 169(4): 1238 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Davenport and B. K. Yoder An incredible decade for the primary cilium: a look at a once-forgotten organelle Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1159 - F1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, K. Harada, K. Kizawa, T. Sanzen, S. Furubo, M. Yasoshima, S. Ozaki, M. Ishibashi, and Y. Nakanuma Activation of the MEK5/ERK5 Cascade Is Responsible for Biliary Dysgenesis in a Rat Model of Caroli's Disease Am. J. Pathol., January 1, 2005; 166(1): 49 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. Masyuk, B. Q. Huang, A. I. Masyuk, E. L. Ritman, V. E. Torres, X. Wang, P. C. Harris, and N. F. LaRusso Biliary Dysgenesis in the PCK Rat, an Orthologous Model of Autosomal Recessive Polycystic Kidney Disease Am. J. Pathol., November 1, 2004; 165(5): 1719 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bettini, L. Mandrioli, and M. Morini Bile Duct Dysplasia and Congenital Hepatic Fibrosis Associated with Polycystic Kidney (Caroli Syndrome) in a Rat Vet. Pathol., November 1, 2003; 40(6): 693 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
C A Johnson, P Gissen, and C Sergi Molecular pathology and genetics of congenital hepatorenal fibrocystic syndromes J. Med. Genet., May 1, 2003; 40(5): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bergmann, J. Senderek, B. Sedlacek, I. Pegiazoglou, P. Puglia, T. Eggermann, S. Rudnik-Schneborn, L. Furu, L. F. Onuchic, M. de Baca, et al. Spectrum of Mutations in the Gene for Autosomal Recessive Polycystic Kidney Disease (ARPKD/PKHD1) J. Am. Soc. Nephrol., January 1, 2003; 14(1): 76 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagasawa, S. Matthiesen, L. F. Onuchic, X. Hou, C. Bergmann, E. Esquivel, J. Senderek, Z. Ren, R. Zeltner, L. Furu, et al. Identification and Characterization of Pkhd1, the Mouse Orthologue of the Human ARPKD Gene J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2246 - 2258. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |